BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2475404)

  • 1. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
    Castella A; Davey FR; Kurec AS; Thompson NA
    Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
    Orazi A; Cattoretti G; John K; Neiman RS
    Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):245-50. PubMed ID: 2475404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of composite nodal B-cell lymphoma and subsequent Hodgkin's disease by flow cytometry and immunohistochemistry. Case report and review of the literature.
    Dunphy CH; Craver JL; Emerson WA
    Arch Pathol Lab Med; 1997 Jun; 121(6):637-40. PubMed ID: 9199634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow in malignant lymphoma.
    McKenna RW; Hernandez JA
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):617-35. PubMed ID: 3065322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery in the diagnosis and interdisciplinary treatment of malignant lymphomas].
    Rock T
    Radiol Med; 1976; 62(7-8):536-41. PubMed ID: 802920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biologic markers in non-Hodgkin's lymphomas.
    Grogan TM; Miller TP
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):925-33. PubMed ID: 1938761
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.